Anapen recalled
The MHRA has advised (PDF) that the manufacturer of Anapen® has recalled the product as a precautionary measure.
Anapen is an adrenaline auto-injector used for treating anaphylaxis in people with severe allergies. A possible issue has been identified that may result in inadequate doses of adrenaline being deliver and in the worst case none at all. There are currently no known cases where this has actually occurred.
It is recommended that patients in possession of an Anapen obtain an alternative from their doctor and then return the Anapen for appropriate destruction.
Action: Clinicians should be aware of this recall. It may be prudent to contact patients directly where adrenaline auto-injectors have been prescribed as the Anapen brand.
« New atomoxetine safety recommendations | SMC Update - June 2012 » |
As a First aid Trainer, should I continue to demonstrate the Anapen in the Anaphylaxis sessions I deliver and should I mention the above situation.
With thanks
Comment by Maria Fallon — September 4, 2012 #
@Maria,
If your learners may be exposed to the pen and need to use it then training should continue but I think they should also be made aware of this situation.
Comment by Matthew Robinson — September 4, 2012 #